Previous Article | Next Article 
Infection and Immunity, June 2000, p. 3116-3120, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Effect of Preexisting Immunity to Salmonella on the
Immune Response to Recombinant Salmonella enterica Serovar
Typhimurium Expressing a Porphyromonas gingivalis
Hemagglutinin
James J.
Kohler,
Latha B.
Pathangey,
Sheila R.
Gillespie, and
Thomas A.
Brown*
Department of Oral Biology, University of
Florida, Gainesville, Florida 32610
Received 13 October 1999/Returned for modification 10 December
1999/Accepted 3 March 2000
Recombinant Salmonella strains expressing foreign
heterologous genes have been extensively studied as live oral vaccine
delivery vectors. We have investigated the mucosal and systemic immune responses following oral immunization with a recombinant
Salmonella enterica serovar Typhimurium expressing the
hemagglutinin HagB from Porphyromonas gingivalis, a
suspected etiological agent of adult periodontal disease. We have
previously shown a primary mucosal and systemic response following oral
immunization with
4072/pDMD1 and recall responses following boosting
at 14 weeks after primary immunization. In this study, we examined the
effects of earlier boosting as well as the effects of deliberately
induced immunity to the Salmonella carrier strain on
subsequent immune responses. Mice boosted at week 7 following
immunization, a point which corresponded to the peak of the primary
response, generally showed lower responses than those boosted at week
14. When mice were preimmunized with the Salmonella carrier
alone and then immunized with the recombinant strain 7 or 14 weeks
later, significant reductions were seen for serum immunoglobulin G
(IgG) antibodies at week 14 and for salivary IgA at week 7. No
reductions were seen in serum IgA or vaginal wash IgA antibodies. Mice
appear to be refractory to boosting with orally administered
salmonellae at 7 weeks. Deliberate immunization with the carrier strain
did not appreciably affect recall responses at 14 weeks, with the
exception of the serum IgG responses, nor did it affect colonization of
the Peyer's patches.
*
Corresponding author. Mailing address: Department of
Oral Biology, P.O. Box 100424, University of Florida, Gainesville, FL 32610. Phone: (352) 846-0780. Fax: (352) 392-7357. E-mail:
tbrown{at}ufl.edu.
Infection and Immunity, June 2000, p. 3116-3120, Vol. 68, No. 6
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Saxena, M., Coloe, P. J., Smooker, P. M.
(2009). Influence of Promoter, Gene Copy Number, and Preexisting Immunity on Humoral and Cellular Responses to a Vectored Antigen Delivered by a Salmonella enterica Vaccine. CVI
16: 78-87
[Abstract]
[Full Text]
-
Zhang, P., Martin, M., Michalek, S. M., Katz, J.
(2005). Role of Mitogen-Activated Protein Kinases and NF-{kappa}B in the Regulation of Proinflammatory and Anti-Inflammatory Cytokines by Porphyromonas gingivalis Hemagglutinin B. Infect. Immun.
73: 3990-3998
[Abstract]
[Full Text]
-
Kotton, C. N., Hohmann, E. L.
(2004). Enteric Pathogens as Vaccine Vectors for Foreign Antigen Delivery. Infect. Immun.
72: 5535-5547
[Full Text]
-
Zhang, P., Martin, M., Yang, Q.-B., Michalek, S. M., Katz, J.
(2004). Role of B7 Costimulatory Molecules in Immune Responses and T-Helper Cell Differentiation in Response to Recombinant HagB from Porphyromonas gingivalis. Infect. Immun.
72: 637-644
[Abstract]
[Full Text]
-
Chen, H., Schifferli, D. M.
(2003). Construction, Characterization, and Immunogenicity of an Attenuated Salmonella enterica Serovar Typhimurium pgtE Vaccine Expressing Fimbriae with Integrated Viral Epitopes from the spiC Promoter. Infect. Immun.
71: 4664-4673
[Abstract]
[Full Text]
-
Vindurampulle, C. J., Attridge, S. R.
(2003). Vector Priming Reduces the Immunogenicity of Salmonella-Based Vaccines in Nramp1+/+ Mice. Infect. Immun.
71: 2258-2261
[Abstract]
[Full Text]
-
Vindurampulle, C. J., Attridge, S. R.
(2003). Impact of Vector Priming on the Immunogenicity of Recombinant Salmonella Vaccines. Infect. Immun.
71: 287-297
[Abstract]
[Full Text]
-
Hindle, Z., Chatfield, S. N., Phillimore, J., Bentley, M., Johnson, J., Cosgrove, C. A., Ghaem-Maghami, M., Sexton, A., Khan, M., Brennan, F. R., Everest, P., Wu, T., Pickard, D., Holden, D. W., Dougan, G., Griffin, G. E., House, D., Santangelo, J. D., Khan, S. A., Shea, J. E., Feldman, R. G., Lewis, D. J. M.
(2002). Characterization of Salmonella enterica Derivatives Harboring Defined aroC and Salmonella Pathogenicity Island 2 Type III Secretion System (ssaV) Mutations by Immunization of Healthy Volunteers. Infect. Immun.
70: 3457-3467
[Abstract]
[Full Text]
-
Jespersgaard, C., Zhang, P., Hajishengallis, G., Russell, M. W., Michalek, S. M.
(2001). Effect of Attenuated Salmonella enterica Serovar Typhimurium Expressing a Streptococcus mutans Antigen on Secondary Responses to the Cloned Protein. Infect. Immun.
69: 6604-6611
[Abstract]
[Full Text]
-
Kohler, J. J., Pathangey, L., Hasona, A., Progulske-Fox, A., Brown, T. A.
(2000). Long-Term Immunological Memory Induced by Recombinant Oral Salmonella Vaccine Vectors. Infect. Immun.
68: 4370-4373
[Abstract]
[Full Text]